BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Tsuzuki T, Okada H, Kawahara Y, Takenaka R, Nasu J, Ishioka H, Fujiwara A, Yoshinaga F, Yamamoto K. Proton pump inhibitor step-down therapy for GERD: A multi-center study in Japan. World J Gastroenterol 2011; 17(11): 1480-1487 [PMID: 21472108 DOI: 10.3748/wjg.v17.i11.1480]
URL: https://www.wjgnet.com/1007-9327/full/v17/i11/1480.htm
Number Citing Articles
1
Mohammad Osmani, Freshteh Osmani, Mohammad Amin Pourhoseingholi. Comparison of Decision Tree and Logistic Regression for Prediction of Functional Dyspepsia and Gastroesophageal Reflux Disease in Tehran Province Using Rome IIIModern Care Journal 2019; 16(4) doi: 10.5812/modernc.94669
2
Hólmfridur Helgadóttir, David C. Metz, Sigrún H. Lund, Sveinbjorn Gizurarson, Elin I. Jacobsen, Gudrún A. Asgeirsdóttir, Yrsa Yngadóttir, Einar S. Björnsson. Study of Gender Differences in Proton Pump Inhibitor Dose Requirements for GERDJournal of Clinical Gastroenterology 2017; 51(6): 486 doi: 10.1097/MCG.0000000000000542
3
Marjan Mokhtare, Arezoo Chaharmahali, Mansour Bahardoust, Atefeh Ghanbari, Arash Sarveazad, Roozbeh Naghshin, Farbod Abbaskhanidavanloo. The effect of adding duloxetine to lansoprazole on symptom and quality of life improvement in patients with gastroesophageal reflux diseases: A randomized double-blind clinical trialJournal of Research in Medical Sciences 2021; 26(1): 4 doi: 10.4103/jrms.JRMS_300_19
4
Marcela Forgerini, Stephania Mieli, Patrícia de Carvalho Mastroianni. Safety assessment of omeprazole use: a reviewSao Paulo Medical Journal 2018; 136(6): 557 doi: 10.1590/1516-3180.2018.0019220318
5
Yoshikazu Kinoshita, Hiroto Miwa, Katsuyuki Sanada, Koji Miyata, Ken Haruma. Clinical characteristics and effectiveness of lansoprazole in Japanese patients with gastroesophageal reflux disease and dyspepsiaJournal of Gastroenterology 2014; 49(4): 628 doi: 10.1007/s00535-013-0812-3
6
Charles Muller, Natalie Tapaskar, Robert T. Kavitt. Foregut Surgery2020; : 121 doi: 10.1007/978-3-030-27592-1_14
7
Daniel A. Kroch, Ryan D. Madanick. Medical Treatment of Gastroesophageal Reflux DiseaseWorld Journal of Surgery 2017; 41(7): 1678 doi: 10.1007/s00268-017-3954-2
8
Eric Alan Gaumnitz. Gastroesophageal Reflux and the Lung2012; : 227 doi: 10.1007/978-1-4614-5502-8_12
9
Mychailo Pliatsko. GASTROESOPHAGEAL REFLUX DISEASE – IS THE MODERN TREATMENT STANDARTS SUFFICIENT TO SOLVE THE PROBLEM?Proceedings of the Shevchenko Scientific Society Medical sciences 2017; 49(1): 78 doi: 10.25040/ntsh2017.01.06
10
Problems Associated with Deprescribing of Proton Pump InhibitorsInternational Journal of Molecular Sciences 2019; 20(21): 5469 doi: 10.3390/ijms20215469
11
Akihito Nagahara, Mariko Hojo, Daisuke Asaoka, Hitoshi Sasaki, Sumio Watanabe. A randomized prospective study comparing the efficacy of on-demand therapy versus continuous therapy for 6 months for long-term maintenance with omeprazole 20 mg in patients with gastroesophageal reflux disease in JapanScandinavian Journal of Gastroenterology 2014; 49(4): 409 doi: 10.3109/00365521.2013.878380